Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 9/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.44 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.42 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.42 |
| ▸ | NSD2 | O96028 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18324277 | 0.83 | KMT2A (0.56) | KMT2ATDP1MEN1MAPTALDH1A1 | |
| SCHEMBL27628085 | 0.81 | CYP4F2 (0.58) | KMT2ATDP1MEN1MAPTALDH1A1 | |
| SCHEMBL27773271 | 0.80 | KMT2A (0.56) | KMT2ATDP1MEN1MAPTALDH1A1 | |
| SCHEMBL29995417 | 0.80 | KMT2A (0.56) | KMT2ATDP1MEN1MAPTALDH1A1 | |
| SCHEMBL9511333 | 0.80 | KMT2A (0.56) | KMT2ATDP1MEN1MAPTALDH1A1 | |
| SCHEMBL4216005 | 0.79 | KMT2A (0.54) | KMT2ATDP1MEN1MAPTALDH1A1 | |
| SCHEMBL27447227 | 0.79 | LOXL2 (0.55) | KMT2ATDP1MEN1MAPTALDH1A1 | |
| SCHEMBL28944513 | 0.79 | KMT2A (0.54) | KMT2ATDP1MEN1MAPTALDH1A1 | |
| SCHEMBL1785471 | 0.78 | KMT2A (0.69) | KMT2ATDP1MEN1MAPTALDH1A1 | |
| SCHEMBL10799936 | 0.78 | GPR132 (0.63) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0043150-A1 | Pharmaceutical 2,3 -bis-hydroxybenzyl butane derivatives | AKZO N.V. (NL) | 1982-01-06 | — | — | EP | disclosed |